Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-12-23
1988-07-26
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514210, 514215, 514255, 514256, 514292, 546 81, 546 82, 546 83, 546 84, 544182, 544238, 544333, 544345, 544405, 540479, 540578, A61K 31335, A61K 31435, C07D47114, C07D25306, C07D40114
Patent
active
047600730
ABSTRACT:
Aryl-substituted naphthyridines and pyridopyrazines are disclosed which are useful in treating allergic reactions, inflammation, peptic ulcers and/or hyperproliferative skin disease. Pharmaceutical compositions and methods of treatment employing such compounds are also disclosed.
REFERENCES:
patent: 4596809 (1986-06-01), Sherlock
Goodman et al., The Pharmacological Basis of Therapeutics, 6 Ed., p. 28.
Chem. Pharm. Bull., vol. 17, No. 6, pp. 1290-1294, (1969).
Fourner et al., Bull. la Societe Chemique de France, No. 58, pp. 364-369, (1967).
Chem. Abstract No. 83-779956/40, Mitsubishi Yuka Yak, 6-Alkyl-pyrano-quinoline-4-on-2-carboxylic Acid Derivatives.
Blythin David J.
Shue Ho-Jane
Billups Richard C.
Lee Mary C.
Miller Stephen I.
Nelson James R.
Richter J.
LandOfFree
Aryl-substituted naphthyridine and pyridopyrazine derivatives, u does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aryl-substituted naphthyridine and pyridopyrazine derivatives, u, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryl-substituted naphthyridine and pyridopyrazine derivatives, u will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-258126